Increased incidence of inflammatory bowel disease: The price of the decline of infectious burden?

Current Opinion in Gastroenterology

Volumn 20, Issue 6, 2004, Pages 560-564

  Feillet, Hélène ^a   Bach, Jean François ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Crohn disease; Helminths; Hygiene hypothesis; Inflammatory bowel disease; Probiotics; Toll like receptors; Ulcerative colitis

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; BACTERIAL INFECTION; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INCIDENCE; NONHUMAN; REVIEW;

EID: 7444271526     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200411000-00010     Document Type: Review

References (47)

1. Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517. An up-to-date recent review on the epidemiology of IBD in the context of the role on environmental factors.
2. Binder V: Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004, 18:463-479.
3. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
4. Yang SK, Loftus Ev JR, Sandborn WJ: Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001, 7:260-270.
5. Blanchard JF, Bernstein CN, Wajda A, et al.: Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001, 154:328-335.
6. Gent AE, Hellier MD, Grace RH, et al.: Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994, 343:766-767.
7. Duggan AE, Usmani I, Neal KR, et al.: Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998, 43:494-498.
8. Hampe J, Heymann K, Krawczak M, et al.: Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int J Colorectal Dis 2003, 18:413-417. Inflammatory bowel disease incidence is higher in the first-born child in families. Evidence for the disease protection by exposure to infections.
9. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
10. Elson CO, Cong Y, Lorenz R, et al.: New developments in experimental models of inflammatory bowel disease. Curr Opin Gastroenterol 2004, 20:360-367.
11. Sellon RK, Tonkonogy S, Schultz M, et al.: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998, 66:5224-5231.
12. Hudcovic T, Stepankova R, Cebra J, et al.: The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 2001, 46:565-572.
13. Lodes MJ, Cong Y, Elson CO, et al.: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113:1296-1306. Identification of a target bacterial antigen in Crohn disease finding that supports the etiologic role of bacteria in the disease.
14. Kullberg MC, Ward JM, Gorelick PL, et al.: Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998, 66:5157-5166.
15. Kullberg MC, Andersen JF, Gorelick PL, et al.: Induction of colitis by a CD4(+) T cell clone specific for a bacterial epitope. Proc Natl Acad Sci USA 2003, 100:15830-15835. Direct demonstration of the capacity of bacteria-specific T cells to induce colitis after in vivo transfer in immunoincompetent recipients.
16. Verdu EF, Bercik P, Cukrowska B, et al.: Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clin Exp Immunol 2000, 120:46-50.
17. -/- mice by probiotics is associated with modulation of cytokine production.
18. Schultz M, Veltkamp C, Dieleman LA, et al.: Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10- deficient mice. Inflamm Bowel Dis 2002, 8:71-80.
19. -/- mice.
20. Jijon H, Backer J, Diaz H, et al.: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126:1358-1373. The in vitro effect of probiotics on immune and epithelial can be obtained with DNA extract.
21. Konrad A, Mahler M, Flogerzi B, et al.: Amelioration of murine colitis by feeding a solution of lysed Escherichia coli. Scand J Gastroenterol 2003, 38:172-179.
22. Schultz M, Strauch UG, Linde HJ, et al.: Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 2004, 11:372-378. A well-documented set of experiments demonstrating the prevention of colitis by two strains of Escherichia coli.
23. Steidler L: In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie von Leeuwenhoek Int J Gen M 2002, 82:323-331.
24. Pathmakanthan S, Li CKF, Cowie J, et al.: Lactobacillus plantarum 299: Beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol 2004, 19:166-173. Probiotics modulate the in vitro production of cytokines by inflamed colonic cells derived from IBD patients. An interesting approach to the mode of action to probiotics.
25. Borruel N, Carol M, Casellas F, et al.: Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002, 51:659-664.
26. Elliott DE, Li J, Blum A, et al.: Exposure to schistosome eggs protects mice from TNBS- induced colitis. Am J Physiol Gastrointest Liver Physiol 2003, 284:G385-G391. A clear demonstration that parasite infections may inhibit the onset of colitis in a reliable experimental model.
27. Moreels TG, Nieuwendijk RJ, de Man JG, et al.: Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 2004, 53:99-107.
28. Khan WI, Blennerhasset PA, Varghese AK, et al.: Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun 2002, 70:5931-5937.
29. Braun-Fahrlander C, Riedler J, Herz U, et al.: Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002, 347:869-877.
30. Kalliomaki M, Salminen S, Poussa T, et al.: Probiotics and prevention of atopic disease: 4-year follow- up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
31. Rosenfeldt V, Benfeldt E, Nielsen SD, et al.: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003, 111:389-395.
32. King C, Ilic A, Koelsch K, et al.: Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265-277. Immune response to mycobacteria competes with homeostasis-driven lymphocyte proliferation. Application to the control of autoimmune disease to an experimental model of diabetes.
33. Barthlott T, Kassiotis G, Stockinger B: T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003, 197:451-460.
34. Bach JF: Regulatory T cells under scrutiny. Nat Rev Immunol 2003, 3:189-198.
35. Miller A, Lider O, Weiner HL: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991, 174:791-798.
36. Tian J, Zekzer D, Hanssen L, et al.: Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001, 167:1081-1089.
37. Quintana FJ, Rotem A, Carmi P, et al.: Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol 2000, 165:6148-6155.
38. Eder W, Klimecki W, Yu L, et al.: Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004, 113:482-488. The first demonstration of the association between a TLR gene polymorphism and an immune disorder (asthma).
39. Van Der Kleij D, Van Den Biggelaar AH, Kruize YC, et al.: Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis 2004, 189:1044-1051.
40. Marie JC, Kehren J, Trescol-Biemont MC, et al.: Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 2001, 14:69-79.
41. Matricardi PM, Rosmini F, Ferrigno L, et al.: Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997, 314:999-1003.
42. McIntire JJ, Umetsu SE, Akbari O, et al.: Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001, 2:1109-1116.
43. McIntire JJ, Umetsu SE, MacAubas C, et al.: Hepatitis A virus link to atopic disease. Nature 2003, 425:576. Propensity to develop asthma in hepatitis A virus seropositive subjects is associated with a polymorphism of the hepatitis A virus receptor gene polymorphism suggesting a role for direct modulation of Th2 cells by hepatitis A virus.
44. Shanahan F: Probiotics in inflammatory bowel disease-therapeutic rationale and role. Adv Drug Deliv Rev 2004, 56:809-818. A recent review on the controversial topic of the therapeutic usage of probiotics in IBD, written by one of the major experts in the field.
45. Tamboli CP, Caucheteux C, Cortot A, et al.: Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003, 17:805-820.
46. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
47. Ishikawa H, Akedo I, Umesaki Y, et al.: Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003, 22:56-63.